|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | |||||
| Depreciation and amortization | |||||
| Provision for doubtful accounts | |||||
| Impairment loss on intangible assets and goodwill | |||||
| Gain on extinguishment of debt | |||||
| Loss on divestiture of business | |||||
| Change in fair value of private warrant liability | |||||
| Change in fair value of contingent consideration | |||||
| Change in fair value of derivatives | |||||
| Stock-based compensation | |||||
| Non-cash interest expense | |||||
| Gain on settlement of contingent consideration | |||||
| Other operating activities | |||||
| Change in operating assets and liabilities, net of acquisitions and divestitures | |||||
| Accounts receivable | |||||
| Reinsurance balance due | |||||
| Deferred policy acquisition costs | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Losses and loss adjustment expense reserves | |||||
| Other insurance liabilities, current | |||||
| Deferred revenue | |||||
| Refundable customer deposits | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Capitalized internal use software development costs | |||||
| Purchases of short-term and long-term investments | |||||
| Maturities, sales of short-term and long-term investments | |||||
| Proceeds from sale of business | |||||
| Acquisitions, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from line of credit | |||||
| Proceeds from advance funding | |||||
| Repayments of advance funding | |||||
| Repayments of principal | |||||
| Capped call transactions | |||||
| Proceeds from exercises of warrants | |||||
| Income tax withholdings paid upon vesting of restricted stock units | |||||
| Cash paid for debt issuance costs | |||||
| Repurchase of stock | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Net change in cash, cash equivalents, and restricted cash and cash equivalents | |||||
| Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | |||||
| Cash, cash equivalents, and restricted cash and cash equivalents at end of period | |||||
| Supplemental schedule of non-cash investing and financing activities | |||||
| Non-cash consideration for acquisitions | |||||
| Share repurchases included in accrued expenses and other current liabilities | |||||
| Reduction of earnout liability due to vesting event | |||||
| Non-cash reduction in advance funding arrangement obligations | |||||
| Non-cash reduction of convertible notes, net | |||||
| Non-cash additions of internally developed software | |||||
| Non-cash warrant exercises | |||||
| Supplemental disclosures | |||||
| Cash paid for interest | |||||
| Income taxes paid (refunded) | |||||
Loading...